vs
Side-by-side financial comparison of ORTHOPEDIATRICS CORP (KIDS) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $61.6M, roughly 1.3× ORTHOPEDIATRICS CORP). ORTHOPEDIATRICS CORP runs the higher net margin — -16.4% vs -38.1%, a 21.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 17.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 17.4%).
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
KIDS vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $61.6M | $83.1M |
| Net Profit | $-10.1M | $-31.6M |
| Gross Margin | 73.2% | 64.9% |
| Operating Margin | -13.3% | -4.1% |
| Net Margin | -16.4% | -38.1% |
| Revenue YoY | 17.0% | 20.2% |
| Net Profit YoY | 37.1% | -27.9% |
| EPS (diluted) | $-0.43 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $61.6M | $76.4M | ||
| Q3 25 | $61.3M | $83.3M | ||
| Q2 25 | $61.1M | $79.2M | ||
| Q1 25 | $52.4M | $69.2M | ||
| Q4 24 | $52.7M | $68.2M | ||
| Q3 24 | $54.6M | $58.4M | ||
| Q2 24 | $52.8M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $-10.1M | $-29.8M | ||
| Q3 25 | $-11.8M | $-21.4M | ||
| Q2 25 | $-7.1M | $-19.6M | ||
| Q1 25 | $-10.7M | $-24.7M | ||
| Q4 24 | $-16.1M | $-18.9M | ||
| Q3 24 | $-7.9M | $-21.0M | ||
| Q2 24 | $-6.0M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 73.2% | 60.6% | ||
| Q3 25 | 73.9% | 64.8% | ||
| Q2 25 | 72.1% | 65.4% | ||
| Q1 25 | 73.0% | 63.9% | ||
| Q4 24 | 67.5% | 64.0% | ||
| Q3 24 | 73.4% | 63.2% | ||
| Q2 24 | 77.3% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | -13.3% | -40.6% | ||
| Q3 25 | -15.4% | -27.8% | ||
| Q2 25 | -17.4% | -28.0% | ||
| Q1 25 | -21.0% | -39.7% | ||
| Q4 24 | -26.7% | -28.9% | ||
| Q3 24 | -10.2% | -38.4% | ||
| Q2 24 | -10.7% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | -16.4% | -39.1% | ||
| Q3 25 | -19.2% | -25.7% | ||
| Q2 25 | -11.6% | -24.7% | ||
| Q1 25 | -20.3% | -35.8% | ||
| Q4 24 | -30.5% | -27.6% | ||
| Q3 24 | -14.5% | -35.9% | ||
| Q2 24 | -11.4% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $-0.43 | $-0.54 | ||
| Q3 25 | $-0.50 | $-0.38 | ||
| Q2 25 | $-0.30 | $-0.35 | ||
| Q1 25 | $-0.46 | $-0.45 | ||
| Q4 24 | $-0.70 | $-0.34 | ||
| Q3 24 | $-0.34 | $-0.40 | ||
| Q2 24 | $-0.26 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.9M | $245.6M |
| Total DebtLower is stronger | $106.0M | $51.7M |
| Stockholders' EquityBook value | $346.6M | $347.7M |
| Total Assets | $508.6M | $487.1M |
| Debt / EquityLower = less leverage | 0.31× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $60.9M | $286.5M | ||
| Q3 25 | $57.7M | $294.3M | ||
| Q2 25 | $70.1M | $302.7M | ||
| Q1 25 | $58.8M | $316.2M | ||
| Q4 24 | $68.8M | $333.7M | ||
| Q3 24 | $76.1M | $196.8M | ||
| Q2 24 | $28.9M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $106.0M | $51.6M | ||
| Q3 25 | $105.3M | $51.6M | ||
| Q2 25 | $102.7M | $51.5M | ||
| Q1 25 | $77.4M | $51.5M | ||
| Q4 24 | $77.5M | $51.5M | ||
| Q3 24 | $76.9M | $51.4M | ||
| Q2 24 | $11.2M | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $346.6M | $365.9M | ||
| Q3 25 | $349.3M | $380.3M | ||
| Q2 25 | $355.5M | $385.8M | ||
| Q1 25 | $347.1M | $389.2M | ||
| Q4 24 | $354.6M | $402.2M | ||
| Q3 24 | $370.9M | $241.2M | ||
| Q2 24 | $371.3M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $508.6M | $508.1M | ||
| Q3 25 | $493.5M | $511.5M | ||
| Q2 25 | $503.6M | $513.1M | ||
| Q1 25 | $470.3M | $519.4M | ||
| Q4 24 | $473.2M | $534.0M | ||
| Q3 24 | $489.3M | $374.1M | ||
| Q2 24 | $430.8M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.31× | 0.14× | ||
| Q3 25 | 0.30× | 0.14× | ||
| Q2 25 | 0.29× | 0.13× | ||
| Q1 25 | 0.22× | 0.13× | ||
| Q4 24 | 0.22× | 0.13× | ||
| Q3 24 | 0.21× | 0.21× | ||
| Q2 24 | 0.03× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.3M | — |
| Free Cash FlowOCF − Capex | $9.7M | — |
| FCF MarginFCF / Revenue | 15.8% | — |
| Capex IntensityCapex / Revenue | 1.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $10.3M | $-10.3M | ||
| Q3 25 | $-581.0K | $-6.6M | ||
| Q2 25 | $-10.5M | $-15.0M | ||
| Q1 25 | $-4.2M | $-17.0M | ||
| Q4 24 | $-4.0M | $-32.4M | ||
| Q3 24 | $-10.3M | $-18.8M | ||
| Q2 24 | $-6.1M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $9.7M | $-12.2M | ||
| Q3 25 | $-3.4M | $-9.5M | ||
| Q2 25 | $-13.9M | $-17.8M | ||
| Q1 25 | $-8.4M | $-18.8M | ||
| Q4 24 | $-4.2M | $-33.6M | ||
| Q3 24 | $-11.7M | $-19.0M | ||
| Q2 24 | $-12.8M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 15.8% | -15.9% | ||
| Q3 25 | -5.6% | -11.4% | ||
| Q2 25 | -22.8% | -22.5% | ||
| Q1 25 | -16.0% | -27.2% | ||
| Q4 24 | -8.1% | -49.2% | ||
| Q3 24 | -21.4% | -32.6% | ||
| Q2 24 | -24.2% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.0% | 2.4% | ||
| Q3 25 | 4.6% | 3.4% | ||
| Q2 25 | 5.6% | 3.5% | ||
| Q1 25 | 8.1% | 2.7% | ||
| Q4 24 | 0.5% | 1.7% | ||
| Q3 24 | 2.5% | 0.4% | ||
| Q2 24 | 12.7% | 2.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KIDS
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
